PENUMBRA INC (PEN:NYSE)
$318.1 0.15 (0.0472%)
Analysed PENUMBRA INC (PEN:NYSE) News Sources
Boston Scientific Eyes Neurovascular Growth With Penumbra Thunderbolt Clearance
13-06-2026
yahoo.com
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
15-06-2026
yahoo.com
Penumbra’s Thunderbolt approval poised to accelerate neuro thrombectomy innovation
16-06-2026
medicaldevice-network.com
Medtech M&A maintains momentum following decade-high 2025: PwC
17-06-2026
medtechdive.com
Penumbra wins CE mark for Thunderbolt clot removal tech
18-06-2026
medtechdive.com
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
18-06-2026
yahoo.com
Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain?
18-06-2026
yahoo.com
GMED vs. PEN: Which Stock Should Value Investors Buy Now?
22-06-2026
yahoo.com
GuideAI Health Appoints Renowned Interventional Radiologist Dr. James Benenati to Advisory Board Following FDA 510(k) Clearance of VAOT
06-07-2026
yahoo.com
First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke
07-07-2026
yahoo.com
What is the current price of PENUMBRA INC (PEN:NYSE)?
The current price of PENUMBRA INC (PEN:NYSE) is $318.1.
PENUMBRA INC (PEN:NYSE) absolute price change since previous trading day?
The absolute price change of PENUMBRA INC (PEN:NYSE) since the previous trading day is $0.15.
PENUMBRA INC (PEN:NYSE) percentage price change since previous trading day?
The percentage price change of PENUMBRA INC (PEN:NYSE) since the previous trading day is 0.0472%.
What is the most recent average sentiment score for PENUMBRA INC (PEN:NYSE)?
The most recent average sentiment score for PENUMBRA INC (PEN:NYSE) is 76 out of 100.
What is the most recent average sentiment for PENUMBRA INC (PEN:NYSE)?
The most recent sentiment for PENUMBRA INC (PEN:NYSE) is .
SEC-8K** Filing Available For PENUMBRA INC (PEN:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.